‘Virtual clinical trials’ may predict success of heart failure drugs

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world’s most pressing health challenges. By combining advanced computer modeling with real-world patient data, the team has created “virtual clinical trials” that may facilitate the discovery of effective therapies while reducing the time, cost, and risk of failed studies.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup